Navigation Links
Universal Binder - 2-Panel

ProductsUniversal Binder - 2-Panel
Company Contemporary Design Inc.
Item Universal Binder - 2-Panel
Features 
  • The two panels provide adjustment to the contour of the patients upper and lower abdomen
  • The finished edges prevent irritation in surgical areas
  • Available in 10 and 12 widths
Description CDIs 2-Panel Abdominal Binders are designed with a foam backing which provides comfort, support and compression without slippage.
Info Contemporary Design Inc.
Customer Service: (610) 923.7648
Web site: http://www.contemporarydesigninc.com/

Related medicine products :

1. Universal Handle for Blades
2. Universal Trephine Handle with Cottingham Punch
3. Storz Universal Trephine Handle
4. Universal Conformer
5. Universal Eye Shield - child
6. Universal Eye Shield - adult
7. Universal Goffman Blue Eye Garter Shield Cover and Blue Eye Shield
8. Universal Trial Frames UB4
9. Universal Folding Forcep
10. Fine Universal II Inserter
11. Panther Universal Spinal Retractor System
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish.
Narrow 4 mm long smooth platform. Serrated handle with polished finish.
1 mm smooth 45 degrees angled jaws. Cross action serrated handle with polished finish.
Oval solid 16 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Serrated handle with locking thumb screw and polished finish.
Medicine Products:
(Date:10/7/2008)...han 4,300 Activity Bags Donated to Area Youth in H...nio, HOUSTON, Oct. 7 /PRNewswire/ -- Carlson Hote...ether to provide more than 1,900 activity bags,to ... area. The tote bags,contained a fun activity book...., (Photo: http://www.newscom.com/cgi-bin/prnh/2...
(Date:10/7/2008)...N, N.J., Oct. 7 /PRNewswire-FirstCall/ -- Majesco ...ive provider of video games for the mass,market, t...matum 2009 has,gone gold and is scheduled to ship ... of its kind to integrate a celebrity fitness trai... life coach on the popular television,series "The ...
(Date:10/7/2008)...Y, France, October 7 /PRNewswire-FirstCall/ -- Sta...red into an exclusive agreement with,Catalent for ...line,autoinjector, ADREFLEX(R), co-developed and c...LC., ADREFLEX(R) consists of a syringe pre-filled...t and paediatric use (0.3 and 0.15 mg), in an,auto...
(Date:10/7/2008)...LAND, Oct. 7 /PRNewswire/ -- Cleveland Medical Dev... $1.23 million in NIH SBIR,FastTrack funding from ...une(TM), a system to augment stimulator programmin...arkinson,s disease (PD). CleveMed is,collaborating...storation of,the Cleveland Clinic Foundation, a wo...
Breaking Medicine News(10 mins):Health News:Carlson Hotels Worldwide Partners With the American Red Cross in Texas to Provide Relief for Children Affected by Hurricane Ike 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 3Health News:Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe 2Health News:CleveMed Receives $1.23 Million in NIH Funding to Develop a System to Augment Deep Brain Stimulation Programming in Parkinson's Disease 2
...er of the Bernhard Nocht Institute for Tropical Me...arial //parasite avoids the immune system by killi...s known that after infecting man, malarial parasit...ct the red blood cells, but it was not known how t...
...sity, University of California-Davis and Justus-Li...treatments //could be possible for autism and Park...focused their attention despite being distracted u...t a measure of cognitive deficit in mice that is r...
... are born infected with human cytomegalovirus, or ...anent disabilities due to the virus – almost one a...oss, vision loss, mental disability, a lack of coo... for Disease Control and Prevention, CMV is as com...
...from infection causing agents. Regulatory T-cells,...s of life itself to recognize// the invaders and d...ese cells seem to protect certain bacteria, viruse...ical college of Georgia, studied the T-cells in th...
Other Medicine News:Health News:Scientist Study New Treatment Modality for Psychiatric Disorders Using Mice 2Health News:Scientist Study New Treatment Modality for Psychiatric Disorders Using Mice 3Health News:Innovative Method for Creating a Human Cytomegalovirus Vaccine Outlined 2Health News:Regulatory T-cells – Protector or Cause of Diseases 2Health News:Regulatory T-cells – Protector or Cause of Diseases 3
(Date:10/7/2008)... A study published in the,scientific journal Natur...rted that InVitria,s ( http://www.InVitria.com ) C...effective replacement to bovine serum albumin,in E...d state of embryonic stem cell,self-renewal," disc...nant,albumin in place of animal-derived serum to e...
(Date:10/7/2008)...ligen Therapeutics Inc.,today announced that in vi...dates were presented at the XXII International Com...ighlighted the candidates, efficacy in,several ani...se highlighted presentations, as well as several i...l the deep expertise and expanding,knowledge base ...
(Date:10/7/2008)...g-term benefits and value in,moderate to severe Cr...ge,of Gastroenterology (ACG), ORLANDO, Fla. Oct. ...presented this week by UCB at the American College...ate that CIMZIA(R) (certolizumab pegol) - the,only...lpha) - provides,sustained improvement in symptoms...
(Date:10/7/2008)... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) announce...and Highly Selective MEK1/2 Inhibitor is Beneficia...ic Colitis in Mice," was presented at the,American...ting in Orlando,Florida. The poster, which provid...ompany,s lead mitogen-activated ERK kinase (MEK) i...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Philadelphia Insurance Companies Launches Home Health Care and Hospice Products 20892 1Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 1Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2294 8Breast Feeding More Protective for Girls Than Boys 20888 1Breast Feeding More Protective for Girls Than Boys 20888 2Boca Pharmacal Receives FDA Approval for Carbinoxamine Maleate 4 mg Tablet 20882 1